1Authors/Task Force Members,McMurray JJ, Adamopoulos S,et al [DB/OL]. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart FaiLure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J ,2012. [ 2012-06-02 ]. http://eurheartj, oxfordjoumals org/content/early/2012/05/17/eurheartj.
2Oginosawa Y, Abe H, Nakashima Y, The incidence and risk factors for venous obstruction after implantation of transvenous pacing leads. Pacing Clin Electrophysiol,2002,25:1605-1611.
3Voigt A, Shalaby A, Saba S. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J Am Coil Cardiol, 2006, 48: 590-591.
4Baddour LM, Epstein AE, Erickson CC, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation,2010, 121:458-477.
5Margey R, McCann H, Blake G, et al. Contemporary management of and outcomes from cardiac device related infections. Europace, 2010, 12: 64-70.
